Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Aronson

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Psychological Trauma : Theory, Research, Practice and Policy|July 3, 2020
The impact of adverse childhood experiences (ACEs) and combat exposure on mental health conditions among new post-9/11 veteransKeith R Aronson, Daniel F Perkins, Nicole R Morgan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 16, 2025
Inhibition of the MRTF-A/SRF signaling axis alleviates vocal fold scarringRyan M Friedman, Huy D Truong, Matthew R Aronson, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian CancersMatthew R Aronson, Erika S Dahl, Jacob A Halle, et al.
BMC Health Services Research|June 12, 2020
Reducing barriers to post-9/11 veterans' use of programs and services as they transition to civilian lifeNicole R Morgan, Keith R Aronson, Daniel F Perkins, et al.
Journal of the National Cancer Institute|July 18, 1990
High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinomaJ S Abrams, A A Rayner, P H Wiernik, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanomaK Margolin, F R Aronson, M Sznol, et al.
Journal of the American Medical Informatics Association : JAMIA|September 8, 2010
Extracting Rx information from clinical narrativeJames G Mork, Olivier Bodenreider, Dina Demner-Fushman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effectsJ A Sosman, G R Weiss, K A Margolin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Controlled decorin delivery from injectable microgels promotes scarless vocal fold repairRyan M Friedman, Elizabeth A Brown, Hannah M Bonelli, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in Hodgkin's disease and non-Hodgkin's lymphomaK A Margolin, F R Aronson, M Sznol, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Psychological Trauma : Theory, Research, Practice and Policy|July 3, 2020
The impact of adverse childhood experiences (ACEs) and combat exposure on mental health conditions among new post-9/11 veteransKeith R Aronson, Daniel F Perkins, Nicole R Morgan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 16, 2025
Inhibition of the MRTF-A/SRF signaling axis alleviates vocal fold scarringRyan M Friedman, Huy D Truong, Matthew R Aronson, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian CancersMatthew R Aronson, Erika S Dahl, Jacob A Halle, et al.
BMC Health Services Research|June 12, 2020
Reducing barriers to post-9/11 veterans' use of programs and services as they transition to civilian lifeNicole R Morgan, Keith R Aronson, Daniel F Perkins, et al.
Journal of the National Cancer Institute|July 18, 1990
High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinomaJ S Abrams, A A Rayner, P H Wiernik, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanomaK Margolin, F R Aronson, M Sznol, et al.
Journal of the American Medical Informatics Association : JAMIA|September 8, 2010
Extracting Rx information from clinical narrativeJames G Mork, Olivier Bodenreider, Dina Demner-Fushman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effectsJ A Sosman, G R Weiss, K A Margolin, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Controlled decorin delivery from injectable microgels promotes scarless vocal fold repairRyan M Friedman, Elizabeth A Brown, Hannah M Bonelli, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in Hodgkin's disease and non-Hodgkin's lymphomaK A Margolin, F R Aronson, M Sznol, et al.
Pageof 26